Watson Marlow Fluid Technology Solutions
Watson Marlow Solutions is the world leader in peristaltic pumps and associated fluid path technologies for the food, pharmaceutical, chemical and environmental industries. Comprising ten established brands, each with their area of expertise, but together offering our customers unrivalled solutions for their pumping and fluid transfer applications.
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Related Content
Manufacturing
Optimising bioprocess skid functionality with low shear, low pulsation pumps
CPi Biotech makes use of a range of peristaltic pumps from Watson-Marlow Fluid Technology Solutions (WMFTS) to ensure that its skid platforms provide major multinational biopharmaceutical companies with the flexibility to manage multiple processes
Manufacturing
What should you consider when scaling fill/finish for cell and gene therapy?
No matter what area you’re working in, transitioning from the lab to commercial manufacturing presents significant challenges. Cell and gene therapies are no different and production quantities must scale at multiple stages — first to support clinical trials and then when they reach the market
Regulatory
What to consider for successful GMP Annex 1 implementation
In advance of her presentation at Manufacturing Chemist Live, Dr Nicole Hunter (NH), Head of Global Regulatory and Validation Services at Watson-Marlow Fluid Technology Solutions, and colleague Claire Hutchison (CH), Life Science Specialist, provide their insights on the updates to the European Commission’s Good Manufacturing Practices (GMP) Annex 1 and the role of single-use systems
Manufacturing
Advaxia Biologics achieves greater operational efficiency with Flexicon FPC60 vial filler
The Flexicon FPC60 vial fill/finish system and environmental barrier technology from Franz Ziel GmbH provides a flexible, efficient and high-precision filling/capping solution for aseptic processing
Manufacturing
Cell and gene therapies: on the brink of commercialisation
With their one-and-done potential and pinpoint targeting capability, cell and gene therapies (CGTs) offer huge promise in the fight against a range of previously untreatable diseases. Yet, investment in this sector is not taken lightly. Typically, developers must invest billions of dollars in therapies that might take 10 years to reach the market as they battle the odds against high failure rates
Manufacturing
Watson-Marlow launches augmented reality (AR) app for Bredel hose pump maintenance
Watson-Marlow Fluid Technology Solutions (WMFTS) has launched the Bredel hose pump augmented reality (AR) customer application (app), designed to reduce maintenance time with clear step-by-step visual guidance